GB SCIENCES OTCMKTSGBLX STOCK QUOTE

https://gbsciences.com/

LATEST NEWS FROM GB SCIENCES

Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility

Gb Sciences Targets COVID-19 Treatment as Omicron Variant Arrives

Gb Sciences Accelerates Drug Development via Innovative Biopharma Technology and Strategic Partnerships

Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related Hyperinflammation

Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwright's 23rd Annual Global Investment Conference

Gb Sciences to Present at the SNN Network Summer Virtual Event on Wednesday, August 18th, 2021

GB Sciences Is Developing Plant-Inspired Mixtures for Anxiety, Depression, and Pain From PhAROS, GB Sciences' Proprietary AI-Accelerated Drug Discovery Platform

GB Sciences Using AI Technology in Plant-Based Drug Discovery Research

GB Sciences' Board of Directors Has Passed a Unanimous Written Consent Promoting Dr. Andrea Small-Howard to the Role of President

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform

GB Sciences Publishes Study on Creation of Novel Terpene-Containing Nanoparticles for Pain Relief